Hemoglobin A1c Screening Practices and Characteristics in Youth with Congenital Heart Disease
Pediatric patients with congenital heart disease (CHD) face a higher risk of developing cardiovascular (CV) disease. In adults, acquired conditions like elevated Hemoglobin A1c (HbA1c) are established risk factors for negative cardiovascular outcomes.
Acquired conditions such as elevated Hemoglobin A1c (HbA1c) are known risk factors for adverse CV outcomes in the adult population.
Understanding HbA1c screening and its implications in youth with CHD can provide valuable insight into their long-term cardiovascular health risks.
Additional Resources for Medical Professionals
- e.Med Interdisziplinär: Access to all CME training and professional journals available on SpringerMedizin.de.
- e.Med Pädiatrie: CME education in pediatrics, premium pediatric journal content, including one printed pediatric journal of choice.
- e.Med Innere Medizin: CME education in internal medicine, premium internal medicine journal content, and one printed internal medicine journal of choice.
These resources support clinicians and practitioners in maintaining current knowledge and improving patient care in specialized medical fields.
Author’s summary: Elevated HbA1c is a critical risk factor for cardiovascular disease in youth with congenital heart defects, highlighting the need for targeted screening and professional education.